ALLMedicine™ Lasek Center
Research & Reviews 77 results
https://clinicaltrials.gov/ct2/show/NCT04630158
May 10th, 2022 - This study is a Phase 2 randomized, double-blinded, multi-center, parallel group, placebo-controlled evaluation of the safety and efficacy of SAF312, 5 mg/ml and 15 mg/ml eye drops versus placebo used twice-daily in both eyes for 12 weeks. Eligibl...
https://clinicaltrials.gov/ct2/show/NCT05271422
Mar 9th, 2022 - Duration of study period (per participant): Screening period (0-14 days), Intervention period (12 weeks), F/U period (2 weeks) Patient needs to visit site at least 9 times (Screening, baseline, V1, V2, V3, Tele-visit, V4, V5, F/U Tele-visit). Base...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431912
BMC Ophthalmology; Zhou X, Shen Y et. al.
Sep 11th, 2021 - To assess the effects of warm compress (WC) on tear film lipid layer, blink pattern and Meibomian gland function in patients with dry eye following femtosecond laser small incision lenticule extraction (SMILE) and laser-assisted subepithelial kera...
https://doi.org/10.1097/OPX.0000000000001678
Optometry and Vision Science : Official Publication of Th... Cañadas P, Garcia-Gonzalez M et. al.
Apr 15th, 2021 - The development of confocal microscopy allows one to obtain high-resolution corneal images like its optical density. Some studies have evaluated the optical density with Scheimpflug cameras in the early post-operative period after photorefractive ...
https://emedicine.medscape.com/article/1222702-overview
Mar 2nd, 2021 - Background Laser-assisted subepithelial keratectomy (LASEK) is a laser surgical procedure for the correction of refractive error. LASEK is specifically used to correct astigmatism, hyperopia (farsightedness), and myopia (nearsightedness). It is a ...
Clinicaltrials.gov 10 results
https://clinicaltrials.gov/ct2/show/NCT04630158
May 10th, 2022 - This study is a Phase 2 randomized, double-blinded, multi-center, parallel group, placebo-controlled evaluation of the safety and efficacy of SAF312, 5 mg/ml and 15 mg/ml eye drops versus placebo used twice-daily in both eyes for 12 weeks. Eligibl...
https://clinicaltrials.gov/ct2/show/NCT05271422
Mar 9th, 2022 - Duration of study period (per participant): Screening period (0-14 days), Intervention period (12 weeks), F/U period (2 weeks) Patient needs to visit site at least 9 times (Screening, baseline, V1, V2, V3, Tele-visit, V4, V5, F/U Tele-visit). Base...
https://clinicaltrials.gov/ct2/show/NCT04522427
Aug 21st, 2020 - Recently, the demands for myopia correction and corneal refractive laser surgery are rising with the increased prevalence of myopia. Corneal laser refractive surgery includes photorefractive keratectomy (PRK), laser-assisted in situ keratomileusis...
https://clinicaltrials.gov/ct2/show/NCT04025801
Jul 24th, 2019 - Heidelberg Retina Tomograph (HRT) in vivo Confocal Microscopy to Evaluate the Ocular Surface Disorders of Healthy and Diseased Individuals The purpose of this study is to evaluate the cornea of healthy persons and cases of differ-ent systematic di...
https://clinicaltrials.gov/ct2/show/NCT03569423
Jun 26th, 2018 - Introduction Previous studies document that, although Laser in situ keratomileusis (LASIK) is the most worldwide performed refractive procedure, surface ablation may be safer to avoid flap complications, corneal weakening, and a higher risk of iat...
News 2 results
https://www.medscape.com/viewarticle/769631_1
Abstract and Introduction Abstract Background To compare the corneal high-order aberrations (HOAs), asphericity and regularity after Q-value guided laser in situ keratomileusis (LASIK) and laser epithelial keratomileusis (LASEK) in high myopic ast...
https://www.medscape.com/viewarticle/769631
Abstract and Introduction Abstract Background To compare the corneal high-order aberrations (HOAs), asphericity and regularity after Q-value guided laser in situ keratomileusis (LASIK) and laser epithelial keratomileusis (LASEK) in high myopic ast...
